Cover Image
市場調查報告書

自我血液凝固檢驗市場:至2020年的預測

Coagulation Self-testing to 2020

出版商 Greystone Research Associates 商品編碼 201015
出版日期 內容資訊 英文
商品交期: 最快1-2個工作天內
價格
Back to Top
自我血液凝固檢驗市場:至2020年的預測 Coagulation Self-testing to 2020
出版日期: 2015年06月25日 內容資訊: 英文
簡介

自我血液凝固檢驗市場,由於2個競爭勢力帶來需求不確定性,過去2年中產生變化。抗凝固治療的臨床管理式護理需求雖然有上升趨勢,但由於不需要定期作凝固觀察的新藥物類別的口服抗凝固劑的商品化,預測自我血液凝固檢驗的需求下沉。

本報告提供自我血液凝固檢驗設備市場現狀與市場潛在性、商品化風險與機會、市場面臨的相關課題、市場領導的市場規模和到2020年預測,及企業簡介等相關彙整。

摘要整理

抗凝固治療市場趨勢

  • 抗凝固劑的經濟學
    • 口服抗凝固劑
    • 凝血酵素原時間的監測
    • 競爭的血液凝固檢驗
    • 患者適合性的重要因素
    • 推動市場的要素
    • 產業的整備與競爭環境

自我血液凝固檢驗設備設計因素

  • PT/INR檢驗的標準化
    • 準確度
    • 取樣調查方法
    • 試驗指標檢測
    • 患者/用戶界面
    • 無線技術

商品化因素

  • 管理式護理與償付
    • 第三者患者訓練與支援
    • 特殊技術

市場因素

  • 適應和市場區隔
    • 新的口服抗凝固劑
    • 患者人口統計
    • 法律規章和標準
    • 患者/消費者心理

患者自我檢驗產品評估

  • 市售產品
  • 開發階段的產品

市場分析、資料、預測

  • 北美
  • 西歐
  • 東歐
  • 亞洲
  • 中東、北非
  • 南美

企業簡介

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: CST333F

The size and future potential of the coagulation self-testing market has been evolving over the past 24 months as two competing forces work to inject uncertainty into future demand. Demographic and incidence data indicate a definite upward trend in the clinical and managed care demand for anticoagulation therapeutics. But the commercialization of novel oral anticoagulants (NOACs) -a new class of drugs that does not require routine coagulation monitoring - will work to reduce demand for coagulation self-testing. The result will be a muddled global market where demand among countries and regions will vary based on individual market factors. To minimize risk and fully engage addressable markets, participants must commit to a comprehensive understanding of the key markets in which they currently, or plan to, compete.

Market-driven Product Strategies

A longer life span is expected to translate to a growing number of patients diagnosed with chronic conditions. To counteract the financial and medical infrastructure implications of this trend, pressure from the public sector and managed care organizations will place a premium on therapeutic self-testing and management. In this environment, healthcare sector participants have come to realize that commercial success no longer depends solely on the product itself but also on achieving a consumer-compatible form of packaging and operation.

What You Will Learn

  • What are the marketed patient self-testing devices for measuring and monitoring anticoagulation drug therapy?
  • What is the status and prospects of coagulation self-test devices currently in development?
  • What is the market potential and commercialization risks and opportunities for coagulation self-test devices?
  • What are the key patient self-test device design issues and evolving market factors for coagulation self-testing?
  • What is the impact of coagulation self-test technology and devices on coagulation management markets?
  • What is the role and impact of third-party PT/INR self-test services on device demand and patient acceptance?
  • Who are the market participants in the coagulation self-test segment, and what are their technology and market strategies?
  • Who are the market leaders; what is the size of the market today, and what will it be in 2020?
  • What is the impact of novel oral anticoagulants on the future commercial growth of coagulation self-test devices?

Table of Contents

Summary of Contents

Executive Summary

Anticoagulation Therapy Market Dynamics

  • Anticoagulation Healthcare Economics
    • Oral Anticoagulation Therapy
    • Monitoring Prothrombin Time
    • Competing Coagulation Tests
    • Key Factors in Patient Compliance
    • Market Drivers
    • Industry Alignment and Competitive Landscape

Coagulation Self-Testing Device Design Factors

  • Standardization of PT/INR Testing
    • Accuracy and Precision
    • Sampling Method
    • Endpoint Detection
    • Patient/User Interface
    • Wireless Technology

Commercialization Factors

  • Managed Care and Reimbursement
    • Third-party Patient Training & Support
    • Proprietary Technology

Market Factors

  • Indications and Market Segments
    • Novel Oral Anticoagulants
    • Patient Demographics
    • Regulations and Standards
    • Patient/Consumer Sentiment

Patient Self-Testing Product Assessments

  • Commercial Products
    • CoaguChek
    • CoaguSense
    • InRatio
    • i-STAT
  • Development-Stage Devices
    • iLine Microsystems
    • Microvisk
    • Universal Biosensors
    • FlexLife Health

Market Analysis, Data and Forecasts

  • North America
    • Western Europe
    • Eastern Europe
    • Asia
    • MENA
    • South America

Company Profiles

Back to Top